相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phagocytosis of Apoptotic Cells in Resolution of Inflammation
Ioannis Kourtzelis et al.
FRONTIERS IN IMMUNOLOGY (2020)
From Whipple Disease to Tropheryma whipplei Infection
Didier Raoult
CLINICAL INFECTIOUS DISEASES (2019)
Tumor Necrosis Factor-Alpha Antagonist Interferes With the Formation of Granulomatous Multinucleated Giant Cells: New Insights Into Mycobacterium tuberculosis Infection
Soraya Mezouar et al.
FRONTIERS IN IMMUNOLOGY (2019)
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
J. W. Baddley et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Molecular mechanisms of action of anti-TNF-alpha agents - Comparison among therapeutic TNF-alpha antagonists
Hiroki Mitoma et al.
CYTOKINE (2018)
Treatment with TNF-α inhibitor rectifies M1 macrophage polarization from blood CD14+monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation
Shang-Hung Lin et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2018)
IRF4 haploinsufficiency in a family with Whipple's disease
Antoine Guerin et al.
ELIFE (2018)
Tropheryma whipplei Increases Expression of Human Leukocyte Antigen-G on Monocytes to Reduce Tumor Necrosis Factor and Promote Bacterial Replication
Eya Ben Azzouz et al.
GASTROENTEROLOGY (2018)
TNFα inhibitors exacerbate Mycobacterium paratuberculosis infection in tissue culture: a rationale for poor response of patients with Crohn's disease to current approved therapy
Ahmad Qasem et al.
BMJ OPEN GASTROENTEROLOGY (2018)
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
Michael Croft et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
Ulrike Billmeier et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Systematic review: Whipple's disease (Tropheryma whipplei infection) and its unmasking by tumour necrosis factor inhibitors
T. Marth
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Programmed cell death and its role in inflammation
Yong Yang et al.
MILITARY MEDICAL RESEARCH (2015)
Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis
Luciena C. M. Ortigosa et al.
ACTA DERMATO-VENEREOLOGICA (2014)
Etanercept Exacerbates Inflammation and Pathology in a Rabbit Model of Active Pulmonary Tuberculosis
Liana Tsenova et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Complicated Whipple's disease and endocarditis following tumor necrosis factor inhibitors
Thomas Marth
WORLD JOURNAL OF CARDIOLOGY (2014)
TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species
Francisco J. Roca et al.
CELL (2013)
Anti-Tumor Necrosis Factor-alpha Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
Anne Christine W. Vos et al.
GASTROENTEROLOGY (2011)
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
I. Solovic et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Impaired Immune Functions of Monocytes and Macrophages in Whipple's Disease
Verena Moos et al.
GASTROENTEROLOGY (2010)
Tropheryma whipplei, the Whipple's disease bacillus, induces macrophage apoptosis through the extrinsic pathway
L. Gorvel et al.
CELL DEATH & DISEASE (2010)
Type I Interferon Induction Is Detrimental during Infection with the Whipple's Disease Bacterium, Tropheryma whipplei
Khatoun Al Moussawi et al.
PLOS PATHOGENS (2010)
Confocal Laser Endomicroscopy (CLE) Reveals Mucosal Accumulation of Plga-Nanoparticles in Ulcerous Lesions of Patients With Inflammatory Bowel Diseases
Carsten Schmidt et al.
GASTROENTEROLOGY (2010)
Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor α-expressing cells
Hiroki Mitoma et al.
ARTHRITIS AND RHEUMATISM (2008)
Tumor Necrosis Factor Blockers Influence Macrophage Responses to Mycobacterium tuberculosis
James Harris et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Increased Levels of Circulating IL-16 and Apoptosis Markers Are Related to the Activity of Whipple's Disease
Marie Benoit et al.
PLOS ONE (2007)
Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease
Verena Moos et al.
JOURNAL OF IMMUNOLOGY (2006)
Hepatitis B virus reactivation after cytotoxic chemotherapy: The disease and its prevention
Ayse L. Mindikoglu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2/alternatively activated macrophages
B Desnues et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
IL-16 is critical for Tropheryma whipplei replication in Whipple's disease
B Desnues et al.
JOURNAL OF IMMUNOLOGY (2005)
Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations
R Mahnel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints - Extended report
AI Catrina et al.
ARTHRITIS AND RHEUMATISM (2005)
Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease
T Marth et al.
GASTROENTEROLOGY (2002)
Immunohistological detection of Tropheryma whipplei (Whipple bacillus) in lymph nodes
H Lepidi et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease
T ten Hove et al.
GUT (2002)
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα
D Baeten et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFα receptors
L Berg et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
分享论文
